 |
|
| ADVANCES IN CANCER RESEARCH, 83
| |
| | |
|
|
To order this title, and for more information, click here
George Vande Woude, Director, Van Andel Research Institute, Grand Rapids, MI, USA
George Klein, Karolinska Institutet, Stockholm, Sweden
Included in series
Advances in Cancer Research,
Description
The Advances in Cancer Research series provides invaluable information on the exciting and fast-moving field of cancer
research. This volume presents outstanding and original reviews on a variety of topics, including suppressor and oncogenic roles of
TGF-b and its signaling pathways in tumorigenesis, hereditary diffuse gastric disease, the role of heparan sulfate proteoglycans in cell
signaling and cancer, V-gene mutations in B-cell-derived human malignancy, MHC antigens and tumor escape from immune surveillance, the
role of selection in progressive neoplastic transformation, and the genomic stability, neuronal development, and cancer cross paths of
ATM.
Audience
Researchers and students in the basic and clinical science of cancer biology and oncology, plus related areas in genetics, immunology, pharmacology, cell biology, and molecular biology.
| Bibliographic details |
Hardbound, 261 pages, publication date: OCT-2001
ISBN-13: 978-0-12-006683-4
ISBN-10: 0-12-006683-1
Imprint: ACADEMIC PRESS
|
| Price and Ordering |
Price:
GBP 95
EUR 106.95
USD 156
|  |
Books and book related electronic products are priced in euro (EUR), and Great Britain Pounds (GBP) and US dollars (USD). EUR prices apply in Europe. GBP prices apply to the UK. USD prices apply to the Americas, Asia Pacific and the rest of the world.
|
See also information about conditions of sale & ordering procedures, and links to our regional sales offices.
|
619/121
Last update: 19 Feb 2010
|
|
| |
| | |
|
|
| |
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company